Eli Lilly (LLY) Cash from Operations (2009 - 2026)

Eli Lilly has reported Cash from Operations for 18 years, with the latest figure at 5333000000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 220.11% year-over-year to 5333000000.0; the trailing twelve-month figure through Mar 2026 stood at 20480000000.0 (up 119.79% YoY), and the FY2025 full-year result was 16813000000.0, up 90.67% from the prior year.
• Cash from Operations for Q1 2026 stood at 5333000000.0, up from 3224600000.0 in the prior quarter.
• The five-year high for Cash from Operations was 8835900000.0 in Q3 2025, with the low at 312000000.0 in Q4 2023.
• Historically, Cash from Operations has averaged 2517041176.47 across 5 years, with a median of 2189500000.0 in 2023.
• Annual changes were most pronounced in 2023 — Cash from Operations slumped 118.76% — and 2024, when it surged 892.92%.
• Eli Lilly's Cash from Operations stood at 1662700000.0 in 2022, then slumped by 118.76% to 312000000.0 in 2023, then surged by 892.92% to 2473900000.0 in 2024, then soared by 30.34% to 3224600000.0 in 2025, then soared by 65.38% to 5333000000.0 in 2026.
• The last three Cash from Operations figures came in at 5333000000.0 (Q1 2026), 3224600000.0 (Q4 2025), and 8835900000.0 (Q3 2025), per Business Quant data.